Effective strains 1. Gram-positive aerobic bacteria Streptococcus, such as Streptococcus pneumoniae (including penicillin-resistant bacteria, macrolide-resistant bacteria, ofloxacin, levofloxacin, and quinolone-resistant bacteria and multidrug-resistant bacteria*)ㆍStreptococcus pyogenes (including macrolide-resistant bacteria)ㆍStreptococcus viridansㆍStreptococcus agalactiaeㆍStreptococcus milleriㆍStreptococcus anginosusㆍStreptococcus constellatusㆍStreptococcus mitis, Staphylococcus, such as Staphylococcus aureus (including strains susceptible to methicillin)ㆍStaphylococcus epidermidisㆍStaphylococcus saprophyticusㆍStaphylococcus hemolyticussuch, and Enterococcus, such as Enterococcus faecalisㆍEnterococcus faecium * Multidrug-resistant organisms: Multi-drug resistant pneumococcus refers to a strain that is simultaneously resistant to two or more antimicrobials among penicillins, second generation cephalosporins (such as cefuroxime), macrolides, tetracyclines, and trimethoprim/sulfamethoxazole.
2. Gram-negative aerobic bacteria Haemophilus, such as Haemophilus influenza (including beta-lactamase positive and negative strains)ㆍHaemophilus parainfluenza, Moraxella such as Moraxella catarrhalis (including beta-lactamase positive and negative strains), Klebsiella such as Klebsiella pneumoniaeㆍKlebsiella oxytoca, Escherichia coli, Neisseria such as Neisseria gonorrhoeae, Acinetobacter such as Acinetobacter lwoffiiㆍAcinetobacter anitratusㆍAcinetobacter calcoaceticusㆍAcinetobacter haemolyticus, Citrobacter such as Citrobacter freundiiㆍCitrobacter koseri, Salmonella, Shigella, Enterococcus such as Enterobacter cloacaeㆍEnterobacter aerogenes, Serratia such as Serratia marcescens, Proteus such as Proteus mirabilisㆍProteus vulgaris, Providencia, Morganella such as Morganella morganii, Yersinia, Pseudomonas such as Pseudomonas aeruginosa, Bordetella such as Bordetella pertussis
3. Specific bacteria Coxiella such as Coxiella burnetii, Mycoplasma such as Mycoplasma Pneumonia, Legionella such as Legionella pneumonia, Chlamydia such as Chlamydia pneumoniae
4. Anaerobic bacteria Peptococcus, Clostridium, Fusobacterium, Porphyromonas, Prevotella, Clostridium non-perfringensㆍ Clostridium, Porphyromonas, Prevotella such as Clostridium perfringens
* Diseases for which medicine is efficacious - Acute exacerbation of chronic respiratory disease (chronic bronchitis) - Community-acquired pneumonia - Rhinosinusitis - Otitis media
Fluoroquinolone-based drugs, including this drug, are related to serious adverse events, so acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis are used in patients without other treatment options.
Active Ingredient and Capacity
Gemifloxacin Mesylate 320 mg
Appearance & Packaging Unit White or almost wihte oval film-coated tablets 5 tabets(5 tablets/PTP packaging x 1), 30 tablets(5 tablets/PTP packaging x 6)
Storage In a tight container, store at room temperature (1~30℃)